Morgan Stanley raised the firm’s price target on Sherwin-Williams to $325 from $300 and keeps an Overweight rating on the shares. The firm, which lowered its North American Chemicals industry view to In-Line from Attractive, sees limited base case upside in most places looking into 2024 given its expectations for largely status quo macro at least through the first half of 2024. The firm recommends remaining “barbell positioned” with grinders/compounders on one end and sentiment inflection plays on the other.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SHW:
- Sherwin-Williams price target raised to $301 at BMO Capital, named Top Pick
- Sherwin-Williams price target lowered to $280 from $310 at Citi
- Sherwin-Williams price target lowered to $260 from $285 at Barclays
- Sherwin-Williams price target lowered to $280 from $300 at BMO Capital
- Sherwin-Williams price target raised to $330 from $315 at RBC Capital